Summary
T-Mobile US, Inc. (TMUS) filed an 8-K on March 20, 2025, detailing executive compensation arrangements. The filing primarily concerns amendments to restricted stock unit (RSU) and performance-based restricted stock unit (PRSU) awards for key executives, including Jonathan A. Freier, Callie R. Field, and Ulf Ewaldsson. These amendments adjust the vesting conditions for unvested RSUs and PRSUs in the event of termination without cause or by the executive for good reason, aiming to provide greater clarity and potentially enhanced severance for these executives. Additionally, the report outlines a new compensation letter agreement with Michael J. Katz, President of Marketing, Strategy and Products. This agreement establishes his base salary, short-term and long-term incentive targets, and significantly details his severance package, which includes a substantial lump-sum payment, pro-rata and earned incentive awards, accelerated vesting of equity, and continued benefits in cases of termination without cause or by the executive for good reason. These updates signal a focus on retaining and incentivizing key leadership talent through clearly defined compensation and severance terms.
Key Highlights
- 1Amendments to RSU and PRSU awards for top executives (Freier, Field, Ewaldsson) clarify vesting upon termination without cause or for good reason.
- 2Unvested RSUs will vest on the next scheduled vesting date if termination occurs under specified conditions.
- 3Unvested PRSUs will remain eligible for pro-rated vesting based on actual performance through the end of the performance period post-termination.
- 4New compensation letter agreement established for Michael J. Katz, President of Marketing, Strategy and Products.
- 5Mr. Katz's agreement includes a minimum base salary of $975,000, target STI of 200% of earnings, and target LTI of at least $8,575,000.
- 6Mr. Katz's compensation will be benchmarked against the 50th percentile of a peer group for executive roles starting in calendar year 2026.
- 7Mr. Katz is entitled to significant severance, including 2x base salary + target STI lump sum, pro-rata STI, accelerated equity vesting, and 18 months of continued health benefits upon termination without cause or for good reason.